milrinone and glyburide

milrinone has been researched along with glyburide in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's2 (15.38)18.2507
2000's8 (61.54)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Blas, SD; Davis, FB; Davis, PJ; Mylotte, KM; Warnick, PR1
Fujimoto, S1
Pfaffendorf, M; van Wezel, HB; van Zwieten, PA; Vroom, MB1
Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ1
Gao, F; Parker, JC; VanVolkenburg, MA1
Ikomi, F; Nakamura, K; Ohhashi, T1

Reviews

1 review(s) available for milrinone and glyburide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

12 other study(ies) available for milrinone and glyburide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity.
    Diabetes, 1986, Volume: 35, Issue:9

    Topics: Animals; Calcium; Calcium-Transporting ATPases; Calmodulin; Cell Membrane; Female; Glyburide; Heart; In Vitro Techniques; Male; Milrinone; Myocardium; Pyridones; Rabbits; Thyroxine; Tolazamide; Tolbutamide

1986
Effects of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels.
    European journal of pharmacology, 1994, Nov-24, Volume: 265, Issue:3

    Topics: Animals; Cardiotonic Agents; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Rats; Rats, Wistar; Vasodilator Agents

1994
Effect of phosphodiesterase inhibitors on human arteries in vitro.
    British journal of anaesthesia, 1996, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Amrinone; Analgesics; Anilides; Arginine; Arteries; Dipyridamole; Enoximone; Female; Glyburide; Humans; In Vitro Techniques; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Theophylline; Vasoconstriction; Vasodilation

1996
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
    American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:3 Pt 1

    Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors

2003
Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor.
    Life sciences, 2004, Aug-06, Volume: 75, Issue:12

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Drug Synergism; Glyburide; Insulin; Insulin Secretion; Islets of Langerhans; Milrinone; Models, Biological; Radioimmunoassay; Rats

2004
Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Journal of vascular research, 2006, Volume: 43, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arterioles; Aspirin; Cerebrovascular Circulation; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Milrinone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Pressure; Prostaglandins; Rabbits; Tetrazoles; Vasodilation; Vasodilator Agents

2006